UNIGE document Scientific Article
previous document  unige:82470  next document
add to browser collection
Title

News in angiology and hemostasis

Authors
Published in Revue médicale suisse. 2016, vol. 12, no. 500, p. 13-6
Abstract This update describes contemporary studies of clinical relevance in angiology and hemostasis. We discuss newer developments for the treatment of haemophilia, with a focus on drugs with longer-half lives. Direct anticoagulants (DOAC: rivaroxaban, apixaban, edoxaban and dabigatran) and their approved prescription in Switzerland are summarized, with a description of antidotes that will be available in the near future. We will present new data on the utility of cancer screening at the diagnosis of idiopathic venous thromboembolism (VTE) and on the evaluation of DOAC in patients with cancer-related VTE. Finally, new studies evaluating the clinical risk-benefit of anticoagulation bridging for patients with vitamin K antagonists undergoing procedures do not support the use of such bridging in the majority of patients.
Keywords Anticoagulants/pharmacology/therapeutic useDrug ApprovalHemophilia A/therapyHemostasis/drug effectsHumansSwitzerlandVitamin K/antagonists & inhibitors
Identifiers
PMID: 26946695
Full text
Article (Published version) (547 Kb) - public document Free access
Structures
Research groups Anatomie clinique (134)
La maladie thromboembolique veineuse (808)
Geneva Platelet Group (13)
Citation
(ISO format)
BOEHLEN, Françoise, BLONDON, Marc, FONTANA, Pierre. News in angiology and hemostasis. In: Revue Medicale Suisse, 2016, vol. 12, n° 500, p. 13-6. https://archive-ouverte.unige.ch/unige:82470

190 hits

74 downloads

Update

Deposited on : 2016-04-08

Export document
Format :
Citation style :